Related Experiment Video
Updated: Sep 18, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Hepatitis C Screening in Community Pharmacies-A Feasibility and Knowledge Transfer Study: PHARMA-C
Rose Prévost1,2, Émilie Roy-St-Pierre2,3, Kamilia Idir1,2
1Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Canada.
Community pharmacies in Quebec can feasibly offer rapid hepatitis C virus (HCV) testing. Pharmacists gained confidence, supporting expanded roles in HCV screening and elimination efforts.
Area of Science:
- Public Health
- Infectious Diseases
- Pharmacology
Background:
- Hepatitis C virus (HCV) testing access needs improvement.
- Novel strategies are essential for increasing HCV testing rates.
Purpose of the Study:
- To evaluate the feasibility of rapid HCV testing in Quebec community pharmacies.
- To assess knowledge transfer (KT) among community pharmacists (CPs) regarding HCV testing.
- To identify barriers and facilitators for implementing HCV point-of-care testing.
Main Methods:
- A 6-month prospective KT study (PHARMA-C) involving CPs and health care users (HUs).
- CPs received training on HCV risk factors, rapid antibody testing, counselling, and linkage to care.
- Pre- and post-intervention questionnaires for CPs assessed feasibility and KT; HUs completed satisfaction surveys.
Main Results:
- 32 CPs were recruited; 16 CPs performed 101 HCV tests, identifying 2 positive cases linked to care.
- Post-intervention, CPs reported increased confidence in HCV risk identification, patient communication, and screening.
- 77.8% of CPs deemed HCV screening in pharmacies feasible; key barriers included time constraints and stigma concerns.
Conclusions:
- Point-of-care HCV testing by CPs is feasible in Quebec.
- Expanding pharmacists' scope of practice for HCV screening is encouraged.
- Increased pharmacist involvement can advance the HCV care cascade and elimination goals.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Hepatic Drug Clearance: Role of Transporters
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...